033780.KO KT&G Corp
- Market cap
- KRW 20.2T
- P/E
- 13.9x
- P/B
- 2.07x
- ROE
- 15.4%
- Dividend yield
- 3.00%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 033780.KO undervalued?
Graham number033780.KO trades 13.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
KT&G Corp fundamental analysis
No fundamental analysis for KT&G Corp yet.
KT&G Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About KT&G Corp
KT&G Corporation, together with its subsidiaries, engages in the production, distribution, and sale of tobacco products in South Korea, Europe, and internationally. It provides reconstituent tobacco sheets, red ginseng, red ginseng products, other health foods, food and beverage products, health functional food products, and cosmetic and related products. The company also offers leaf tobacco cultivation support services; and develops, manufactures, and distributes drugs, bio…
Full company profileKT&G Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
KT&G Corp annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 4.50T | 4.67T | 4.47T | 4.96T | 5.30T | 5.23T | 5.85T | 5.86T | 5.91T | 6.58T | 6.81T |
| Gross Profit | 2.71T | 2.76T | 2.64T | 2.87T | 2.97T | 2.88T | 2.96T | 2.81T | 2.90T | 3.14T | 3.37T |
| Operating Income | 1.47T | 1.43T | 1.26T | 1.38T | 1.48T | 1.34T | 1.27T | 1.17T | 1.19T | 1.34T | 1.56T |
| EBITDA | - | 1.57T | 1.48T | 1.65T | 1.82T | 1.67T | 1.69T | 1.54T | 1.86T | 1.82T | 2.40T |
| Net Income | 1.23T | 1.16T | 902B | 1.04T | 1.17T | 977B | 1.02T | 903B | 1.17T | 1.09T | 1.49T |
| EPS | - | 9,217 | 7,141 | 8,188 | 9,443 | 8,145 | 8,736 | 7,763 | 10,625 | 10,344 | 14,349 |
| Balance Sheet | |||||||||||
| Total Assets | 9.81T | 9.98T | 10.2T | 10.7T | 11.5T | 11.6T | 12.3T | 12.8T | 13.9T | 14.2T | 15.0T |
| Total Liabilities | 2.69T | 2.15T | 2.02T | 2.01T | 2.38T | 2.43T | 2.94T | 3.48T | 4.57T | 4.85T | 5.31T |
| Shareholders' Equity | 7.05T | 7.77T | 8.08T | 8.65T | 9.04T | 9.16T | 9.32T | 9.17T | 9.24T | 9.28T | 9.68T |
| Cash & Short-term Investments | 851B | 1.23T | 933B | 891B | 1.25T | 947B | 1.40T | 1.03T | 1.14T | 914B | 1.08T |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.49T | 1.14T | 822B | 1.04T | 1.26T | 1.42T | 888B | 1.27T | 822B | 583B | 1.53T |
| Capital Expenditure | 171B | 320B | 394B | 479B | 303B | 334B | 273B | 515B | 800B | 680B | 479B |
| Free Cash Flow | - | 836B | 462B | 785B | 1.01T | 1.15T | 602B | 751B | 21.9B | -97.4B | 1.05T |
| Ratios | |||||||||||
| ROE | 17.5% | 15.0% | 11.2% | 12.0% | 13.0% | 10.7% | 10.9% | 9.8% | 12.6% | 11.7% | 15.4% |
| ROA | 12.5% | 11.7% | 8.9% | 9.7% | 10.2% | 8.4% | 8.3% | 7.1% | 8.4% | 7.7% | 9.9% |
| Net Profit Margin | 27.3% | 24.9% | 20.2% | 20.9% | 22.1% | 18.7% | 17.4% | 15.4% | 19.7% | 16.6% | 21.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
KT&G Corp dividends
- Dividend yield
- 3.00%
- Forward dividend
- 6,600.00 KRW
- Payout ratio
- 55.4%
- Ex-dividend date
- Aug 20, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 604B | 5,730 | 55.4% |
| 2024 | KRW 587B | 5,347 | 50.3% |
| 2023 | KRW 776B | 6,677 | 86.0% |
| 2022 | KRW 576B | 4,953 | 56.7% |
| 2021 | KRW 596B | 4,964 | 60.9% |
| 2020 | KRW 557B | 4,489 | 47.5% |
| 2019 | KRW 505B | 3,990 | 48.7% |
| 2018 | KRW 505B | 4,000 | 56.0% |
| 2017 | KRW 455B | 3,600 | 39.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns KT&G Corp
- Insiders 5.05%
- Institutions 67.05%
- Public & others 27.91%
- Shares outstanding 104M
- Free float 98.6M
KT&G Corp company profile
- Company name
- KT&G Corp
- Ticker
- 033780.KO
- ISIN
- KR7033780008
- Exchange
- Korea Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Tobacco
- Employees
- 4,084
- Fiscal year end
- December
- Address
- Beotkkot Street 71, Daejeon, South Korea
- Phone
- 82 8 0931 0399
- Website
- ktng.com
About KT&G Corp
KT&G Corporation, together with its subsidiaries, engages in the production, distribution, and sale of tobacco products in South Korea, Europe, and internationally. It provides reconstituent tobacco sheets, red ginseng, red ginseng products, other health foods, food and beverage products, health functional food products, and cosmetic and related products. The company also offers leaf tobacco cultivation support services; and develops, manufactures, and distributes drugs, bio-pharmaceuticals, over-the-counter medicines, and medical supplies and equipment. In addition, it engages in the trading, real estate, leasing, and housing businesses. Further, the company engages in hotel development and management activities. The company was formerly known as Korea Tobacco and Ginseng Corporation and changed its name to KT&G Corporation in December 2002. KT&G Corporation was founded in 1987 and is headquartered in Daejeon, South Korea.
KT&G Corp management
10- Mr. Kyung-Man BangPresident, CEO & Representative Director · born 1971
- Mr. Sang-Hak LeeSenior Executive Vice President, COO, CFO & Director · born 1971
- Mr. Kwang-youl LeeSenior Managing Director and Chief Technology Officer
- Hee-yeon LeeIR director
- Young-Chan YoonChief Marketing Officer
- Mr. Heung-Ryul KimChief Vice President · born 1961
- Mr. Jae-Young ChoChief of Global Business
- Mr. Yong Beom KimHead of Finance Office
- Mr. Chang Gu HuhChief of Strategy & Planning
- Min-Seok KwonHead of International Business